Viewing Study NCT00663559


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-02-25 @ 6:53 PM
Study NCT ID: NCT00663559
Status: COMPLETED
Last Update Posted: 2014-12-18
First Post: 2008-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
Sponsor: Spanish Oncology Genito-Urinary Group
Organization:

Study Overview

Official Title: Study Phase II to Determinate the Efficacy of Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
Status: COMPLETED
Status Verified Date: 2007-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SOGUG/0107
Brief Summary: The purpose of this trial is to determinate the efficacy of Sunitinib in patients with renal cells carcinoma metastasic or locally avanced in patints not candidates to inicial curative nefrectomy.
Detailed Description: Study phase II in with one arm in patients with renal cells carcinoma.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: